WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Results 1-10 of 43 for Criteria: Office(s):all Language:EN Stemming: true maximize
Filters PAF_M:DR. REDDY'S RESEARCH FOUNDATION closeCTR:PCT close
prev 1 2 3 4 5 next
Page: / 5  Go >
RSS icon map icon

Analysis
Analysis

List Length
No translation
NoCtrTitlePubDateInt.ClassAppl.NoApplicantInventor
1. WOWO/2005/000299 - COMPOSITIONS COMPRISING BALAGLITAZONE AND FURTHER ANTIDIABETIC COMPOUNDS06.01.2005
A61K 31/216
PCT/DK2004/000448DR. REDDY'S RESEARCH FOUNDATIONWASSERMANN, Karsten
Methods for the treatment of type 2 diabetes and related conditions comprising the admini-stration of balaglitazone in combination with one or more other antidiabetic compound is pro-vided together with combinations useful in said treatment.

2. WOWO/2003/010157 - DIOXANE DERIVATIVES AND A PROCESS FOR THEIR PREPARATION06.02.2003
C07C 69/63
PCT/IB2001/001314DR. REDDY'S RESEARCH FOUNDATIONPOTLAPALLY, Rajender, Kumar
The present invention relates to novel antidiabetic compounds, their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs and pharmaceutically acceptable compositions containing them. More particularly, the present invention relates to novel dioxane compounds of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs and pharmaceutically acceptable compositions containing them. wherein R1 represents hydrogen or (C1-C6)alkyl group; n is an integer ranging from 1 to 2.

3. WOWO/2003/002550 - DIOXALANE DERIVATIVES AND A PROCESS FOR THEIR PREPARATION09.01.2003
C07D 317/34
PCT/IN2001/000127DR. REDDY'S RESEARCH FOUNDATIONAKELLA, Venkateswarlu
The present invention relates to novel antidiabetic compounds, their derivatives, their analogs, their polymorphs and pharmaceutically acceptable compositions containing them. More particularly, the present invention relates to novel dioxalane of the general formula (I), their derivatives, their analogs, their polymorphs and pharmaceutically acceptable compositions containing them, wherein R?1 and R2¿ may be same or different and represent hydrogen, (C¿1-6?) alkyl or unsubstituted or substituted phenyl or R?1 and R2¿ together may form a 5 or 6 membered cyclic structure.

4. WOWO/2003/002508 - DERIVATIVES OF PARA-ETHOXY-PHENILLACTIC ACID09.01.2003
C07C 69/734
PCT/IN2001/000125DR. REDDY'S RESEARCH FOUNDATIONPOTLAPALLY, Rajender, Kumar
The present invention relates to novel antidiabetic compounds, their derivatives, their analogs, their polymorphs and pharmaceutically acceptable compositions containing them. More particularly, the present invention relates to novel 3-aryl-α-oxy substituted propanoic acids of the general formula (I), their derivatives, their analogs, their polymorphs and pharmaceutically acceptable compositions containing them where R1 represents hydroxy or a protecting group such as (C¿1?-C8)alkoxy-CH2-O-, mesylate, tosylate, triflate or halogen atom, R?2¿ represents hydrogen or (C¿1?-C6)alkyl group, R?3¿ represents hydrogen, (C¿1?-C6)alkyl, t-butyldimethyl silyl, trimethyl silyl or alkoxymethyl.

5. WOWO/2003/002514 - 3-ARYL-ALPHA-AMINO PROPANOIC ACID DERIVATIVES AND A PROCESS FOR THEIR PREPARATION09.01.2003
C07C 229/36
PCT/IN2001/000126DR. REDDY'S RESEARCH FOUNDATIONGADDAM, Om, Reddy
The present invention relates to novel antidiabetic compounds, their derivatives, their analogs and pharmaceutically acceptable compositions containing them. More particularly, the present invention relates to novel 3-aryl propanoic acid of the general formula (I), their derivatives, their analogs and pharmaceutically acceptable compositions containing them wherein R represents hydroxy or a protecting group such as (C1-C8)alkoxy-CH2-O-, mesylate, tosylate, triflate or halogen atom such as fluorine, chlorine, bromine or iodine.

6. WOWO/2002/062772 - SALTS OF 3-4(4-(2-PHENOXAZIN- OR PHENOTHIAZIN-10-YL)ALKOXY)PHENYL)-2-ALKOXYPROPANOIC ACID DERIVATIVES WITH PPAR ACTIVITY FOR THE TREATMENT OF HYPERLIPIMEDIA AND TYPE II DIABETES15.08.2002
C07D 265/38
PCT/IB2002/000341DR. REDDY'S RESEARCH FOUNDATIONGADDAM, Om, Reddy
The present invention relates to pharmaceutically acceptable salts of compound of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. Their derivatives, their analogs, their tautomeric forms, their steroisomers, their polymorphs, wherein R?1 and R2 may be same or different and independently represent hydrogen, halogen atom such as fluorine, chlorine, bromine or iodine; hydroxy, nitro, cyano or lower alkyl group; X represents a heteroatom selected from oxygen or sulfur; R?3¿ represents hydrogen or lower alkyl group; n is an integer ranging from 1-4; M represents a counter ion or a moiety which forms a pharmaceutically acceptable salt; p is an integer ranging from 1 to 2.

7. WOWO/2002/040460 - A PROCESS FOR THE PREPARATION OF 2-[PHENOTHIAZIN-10-YL] ETHYL METHANE SULPHONATE23.05.2002
C07D 279/26
PCT/IN2001/000201DR. REDDY'S RESEARCH FOUNDATIONGADDAM, Om, Reddy
A process for the preparation of 2-[phenothiazin-10-yl]ethylmethane sulphonate of the formula (1) which comprises : N-alkylating the 10H-phenothiazine with 2-haloethanol in the presence of a polar aprotic solvent and a nucleophilic organic or inorganic base to get 2-[phenothiazin-10-yl]ethanol, mesylating the 2-[phenothiazin-10-yl]ethanol to the compound of formula (1) by treating with methane sulphonyl chloride in the presence of an organic base and an organic solvent and isolating the compound of formula (1) by conventional methods.

8. WOWO/2002/034732 - AN IMPROVED PROCESS FOR THE PREPARATION OF 10H-PHENOXAZINE02.05.2002
C07D 265/38
PCT/IB2000/001535DR. REDDY'S RESEARCH FOUNDATIONGADDAM, Om, Reddy
A process for the preparation of 10H-phenoxazine of the formula (1), which comprises: self condensing 2-aminophenol of the formula (2) condensing 2-aminophenol of the formula (2) with 2-aminophenol of the formula (2) or 2-aminophenol hydrochloride in the presence of iodine and diphenyl ether (as a solvent) wherein the formula (2) and diphenyl ether is used in the ratio of 1 : 1 to 1 : 1.25 with or without additional polar protic high boiling solvent at a temperature in the range of 250 to 280 °C, with or without polar protic high boiling solvent and recovering the resulting 10H-phenoxazine by soxhlet or liquid-liquid extraction.

9. WOWO/2002/034733 - AN IMPROVED PROCESS FOR THE PREPARATION OF 2-[PHENOXAZIN-10-YL]ETHYLMETHANE SULPHONATE02.05.2002
C07D 265/38
PCT/IB2000/001556DR. REDDY'S RESEARCH FOUNDATIONBATCHU, Chandrasekhar
The present invention relates to an improved process for the preparation of 2-[phenoxazin-10-yl]ethylmethane sulphonate of formula (1) which comprises N-alkylating the 10H-phenoxazine with 2-haloethanol or ethylene oxide to get [phenoxazin-10-yl]ethanol, mesylating the 2-[phenoxazin-10-yl]ethanol to the compound of formula (1) by treating with methane sulphonyl chloride in the presence of an organic base and an organic solvent and isolating the compound of formula (1) by conventional methods.

10. WOWO/2002/030914 - SALTS OF BENZOTHIAZINE AND BENZOXAZINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM18.04.2002
C07D 265/36
PCT/IN2001/000175DR. REDDY'S RESEARCH FOUNDATIONGADDAM, Om, Reddy
The present invention relates to pharmaceutically acceptable salts of compound of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. wherein R1 represents hydrogen, halogen atom such as fluorine, chlorine, bromine or iodine; hydroxy, nitro, cyano or lower alkyl group; R2 represents hydrogen, lower alkyl or oxo group; X represents a heteroatom selected from oxygen or sulfur; R3 represents hydrogen or lower alkyl group; n is an integer ranging from 1-4; M represents a counter ion or a moiety which forms a pharmaceutically acceptable salt; p is an integer ranging from 1 to 2.


Results 1-10 of 43 for Criteria: Office(s):all Language:EN Stemming: true
prev 1 2 3 4 5 next